Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brijesh Rathi

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Current Topics in Medicinal Chemistry|December 1, 2018
Antimalarials: Review of Plasmepsins as Drug Targets and HIV Protease Inhibitors InteractionsWhelton A Miller Iii, Joshua Teye, Angela O Achieng, et al.
RSC Medicinal Chemistry|November 15, 2021
A novel compound active against SARS-CoV-2 targeting uridylate-specific endoribonuclease (NendoU/NSP15): <i>in silico</i> and <i>in vitro</i> investigationsSumit Kumar, Yash Gupta, Samantha E Zak, et al.
European Journal of Medicinal Chemistry|June 24, 2022
Designing and development of phthalimides as potent anti-tubulin hybrid molecules against malariaVigyasa Singh, Rahul Singh Hada, Ravi Jain, et al.
Journal of Biomolecular Structure & Dynamics|June 21, 2021
Computational study of novel inhibitory molecule, 1-(4-((2<i>S</i>,3<i>S</i>)-3-amino-2-hydroxy-4-phenylbutyl)piperazin-1-yl)-3-phenylurea, with high potential to competitively block ATP binding to the RNA dependent RNA polymerase of SARS-CoV-2 virusPrem Prakash Sharma, Sumit Kumar, Sukrit Srivastava, et al.
Plos One|October 27, 2015
Hydroxyethylamine Based Phthalimides as New Class of Plasmepsin Hits: Design, Synthesis and Antimalarial EvaluationAnil K Singh, Sumit Rathore, Yan Tang, et al.
Bioorganic & Medicinal Chemistry|September 25, 2021
Design, synthesis, and antiviral activity of phenylalanine derivatives as HIV-1 capsid inhibitorsJing Li, Xiangyi Jiang, Alexej Dick, et al.
Current Topics in Medicinal Chemistry|January 30, 2020
Outwitting an Old Neglected Nemesis: A Review on Leveraging Integrated Data-Driven Approaches to Aid in Unraveling of Leishmanicides of Therapeutic PotentialSamuel K Kwofie, Emmanuel Broni, Bismark Dankwa, et al.
Journal of Biomolecular Structure & Dynamics|November 6, 2020
Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch vaccines, designed by reverse epitomics approach, show potential to cover large ethnically distributed human population worldwideSukrit Srivastava, Sonia Verma, Mohit Kamthania, et al.
RSC Advances|June 10, 2022
Multistage antiplasmodial activity of hydroxyethylamine compounds, <i>in vitro</i> and <i>in vivo</i> evaluationsNeha Sharma, Yash Gupta, Meenakshi Bansal, et al.
Molecules (Basel, Switzerland)|September 23, 2022
Design, Synthesis and Structure-Activity Relationships of Phenylalanine-Containing Peptidomimetics as Novel HIV-1 Capsid Binders Based on Ugi Four-Component ReactionXiangkai Ji, Jing Li, Prem Prakash Sharma, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Current Topics in Medicinal Chemistry|December 1, 2018
Antimalarials: Review of Plasmepsins as Drug Targets and HIV Protease Inhibitors InteractionsWhelton A Miller Iii, Joshua Teye, Angela O Achieng, et al.
RSC Medicinal Chemistry|November 15, 2021
A novel compound active against SARS-CoV-2 targeting uridylate-specific endoribonuclease (NendoU/NSP15): <i>in silico</i> and <i>in vitro</i> investigationsSumit Kumar, Yash Gupta, Samantha E Zak, et al.
European Journal of Medicinal Chemistry|June 24, 2022
Designing and development of phthalimides as potent anti-tubulin hybrid molecules against malariaVigyasa Singh, Rahul Singh Hada, Ravi Jain, et al.
Journal of Biomolecular Structure & Dynamics|June 21, 2021
Computational study of novel inhibitory molecule, 1-(4-((2<i>S</i>,3<i>S</i>)-3-amino-2-hydroxy-4-phenylbutyl)piperazin-1-yl)-3-phenylurea, with high potential to competitively block ATP binding to the RNA dependent RNA polymerase of SARS-CoV-2 virusPrem Prakash Sharma, Sumit Kumar, Sukrit Srivastava, et al.
Plos One|October 27, 2015
Hydroxyethylamine Based Phthalimides as New Class of Plasmepsin Hits: Design, Synthesis and Antimalarial EvaluationAnil K Singh, Sumit Rathore, Yan Tang, et al.
Bioorganic & Medicinal Chemistry|September 25, 2021
Design, synthesis, and antiviral activity of phenylalanine derivatives as HIV-1 capsid inhibitorsJing Li, Xiangyi Jiang, Alexej Dick, et al.
Current Topics in Medicinal Chemistry|January 30, 2020
Outwitting an Old Neglected Nemesis: A Review on Leveraging Integrated Data-Driven Approaches to Aid in Unraveling of Leishmanicides of Therapeutic PotentialSamuel K Kwofie, Emmanuel Broni, Bismark Dankwa, et al.
Journal of Biomolecular Structure & Dynamics|November 6, 2020
Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch vaccines, designed by reverse epitomics approach, show potential to cover large ethnically distributed human population worldwideSukrit Srivastava, Sonia Verma, Mohit Kamthania, et al.
RSC Advances|June 10, 2022
Multistage antiplasmodial activity of hydroxyethylamine compounds, <i>in vitro</i> and <i>in vivo</i> evaluationsNeha Sharma, Yash Gupta, Meenakshi Bansal, et al.
Molecules (Basel, Switzerland)|September 23, 2022
Design, Synthesis and Structure-Activity Relationships of Phenylalanine-Containing Peptidomimetics as Novel HIV-1 Capsid Binders Based on Ugi Four-Component ReactionXiangkai Ji, Jing Li, Prem Prakash Sharma, et al.
Pageof 9